Stryker's earnings call highlighted strong growth in organic sales and innovative product launches, leading to raised full-year guidance. However, challenges such as supply chain issues in the Medical division and tariff impacts were noted. Despite these challenges, the overall sentiment remains positive due to strong performance and strategic advancements.

Company Guidance -

Q3 2025

During Stryker's second quarter 2025 earnings call, the company reported robust financial performance, leading to an upward revision of its full-year guidance. Stryker achieved a 10.2% increase in organic sales growth and an 11.4% rise in adjusted earnings per share (EPS), driven by strong demand across its diverse product portfolio despite facing tariff impacts and supply chain challenges. Notably, U.S. organic sales grew by 11.5%, fueled by double-digit growth in MedSurg and Neurotechnology, while international sales saw a 6.5% increase. The company highlighted its strategic focus on innovation and expansion in international markets as key drivers for future growth. Additionally, Stryker raised its full-year outlook, projecting 100 basis points of adjusted operating margin expansion and adjusted EPS in the range of $13.40 to $13.60. The call also emphasized the successful integration of Inari Medical and the continued momentum of the Mako robotic systems, with a record number of installations in the quarter.

Strong Organic Sales Growth

Stryker achieved double-digit organic sales growth of 10.2% and adjusted EPS growth of 11.4%. U.S. organic sales growth was 11.5%, and international sales growth was 6.5% despite supply chain challenges.

Successful Product Launches and Innovations

Milestones included reaching 2 million robotic procedures with Mako and best-ever Q2 for Mako installations. New applications such as revision hip and Mako Spine and shoulder are progressing well.

Raising Full Year 2025 Outlook

Due to strong performance and operational momentum, Stryker raised its full year guidance to 9.5% to 10% organic net sales growth and adjusted EPS in the range of $13.40 to $13.60.

Endoscopy and Sports Medicine Growth

Endoscopy U.S. organic sales growth was 18.6%, fueled by strong demand for operating room infrastructure and the success of the 1788 video platform. Sports Medicine is expanding with new shoulder products.

Stryker (SYK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SYK Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	3.14 / -	2.87	―	―	―
Jul 31, 2025	2025 (Q2)	3.07 / 3.13	2.81	11.39% (+0.32)	―
May 01, 2025	2025 (Q1)	2.71 / 2.84	2.5	13.60% (+0.34)	―
Jan 28, 2025	2024 (Q4)	3.87 / 4.01	3.46	15.90% (+0.55)	―
Oct 29, 2024	2024 (Q3)	2.77 / 2.87	2.46	16.67% (+0.41)	―
Jul 30, 2024	2024 (Q2)	2.79 / 2.81	2.54	10.63% (+0.27)	―
Apr 30, 2024	2024 (Q1)	2.36 / 2.50	2.14	16.82% (+0.36)	―
Jan 30, 2024	2023 (Q4)	3.27 / 3.46	3	15.33% (+0.46)	―
Nov 02, 2023	2023 (Q3)	2.44 / 2.46	2.12	16.04% (+0.34)	―
Aug 03, 2023	2023 (Q2)	2.38 / 2.54	2.25	12.89% (+0.29)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SYK Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$392.73	$377.79	-3.80%
May 01, 2025	$373.19	$377.41	+1.13%
Jan 28, 2025	$393.40	$389.34	-1.03%
Oct 29, 2024	$356.59	$360.98	+1.23%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Stryker Corporation (SYK) report earnings?

Stryker Corporation (SYK) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).

What is Stryker Corporation (SYK) earnings time?

Stryker Corporation (SYK) earnings time is at Oct 30, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SYK EPS forecast?

SYK EPS forecast for the fiscal quarter 2025 (Q3) is 3.14.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing